Skip to content
Search

Latest Stories

New NPA report reveals medicine shortages warnings triple in last two years

New NPA report reveals medicine shortages warnings triple in last two years
According to the report on medicine shortages between 2022-24, 50 SSPs were issued, compared to just 15 between 2019-21
The Government has been forced to intervene formally 50 times in the past two years to authorise the use of alternative drugs because of serious medicine shortages hitting patients, new analysis by the National Pharmacy Association (NPA) has found today.
78 per cent of all Serious Shortage Protocols, produced by the Department of Health and Social Care (DHSC) due to medicine shortages, were issued in 2022/24 – more than three times the rate in the previous two years.
The NPA, which represents independent community pharmacies in the UK, is warning that shortages are leading to pharmacists having to increasingly turn patients needing vital medication away.
Analysis by the NPA of the NHS’s Serious Shortage Protocols (SSPs) issued to pharmacies and other providers over the last five years has found that:
The number of SSPs issued in the last two years is 3.5 times higher than in the previous two years.
Between 2022-24, 50 SSPs were issued, compared to just 15 between 2019-21.
Four SSPs have been issued in May 2024 in a three-day period for medication shortages, the same number that had been issued for the whole of 2020.
Serious Shortage Protocols are used by the DHSC to permit community pharmacists to supply an alternative quantity, strength or formulation in the event of a shortage of a particular medicine.
SSPs have been issued for a diverse range of medication treating conditions including; angina, menopause symptoms, whooping cough, chest infections, contraception, depression, epilepsy, thyroid problems and anaphylaxis among many others.
Although some SSPs are only in place for a matter of weeks, many extend for months and in one extreme case for several years.
SSPs are an important way for pharmacies to be notified of shortages and provide alternative medication but their more frequent use is evidence of a surge in medicine shortages over the last two years.
The NPA are urging all three main parties to commit during the general election campaign to commit to tackling the alarming growth in medicine shortages that has blighted patients and pharmacies over the last few years.
This week the House of Commons Health and Social Care Committee said it was deeply concerned about medicine shortages and called for an independent review of the medicines supply chain to assess its resilience.
Changes in global demand, fluctuations in prices and exchange rates, manufacturing problems and the structure of the supply chain here in the UK are all factors that combine to impact on the availability of medicine supplies.
The supply of medicines in the UK is grossly underfunded – when compared with other comparable Western nations – which is also a key factor in the problem.

Paul Rees, Chief Executive of the National Pharmacy Association said:

“It’s clear that these growing medicine shortages are heaping pressure on our already stretched local community pharmacy teams.


“The current funding crisis – which has seen support for pharmacies fall by 40 per cent  over the last decade in real terms – is a key issue in driving these appalling shortages.
“The national warnings are only issued when shortages are at their most acute, with this revealing just the tip of the iceberg, in terms of the challenges facing pharmacies and their patients.
“Pharmacists will always help patients get alternative medication, when possible, but they face continual struggles obtaining supply across an ever-changing range of conditions, from diabetes to ADHD and epilepsy.
“Pharmacists are spending hours a day hunting down stock and are often forced to turn patients away due to being unable to order in vital medication.
“It is imperative that all the main parties commit during the general election campaign to addressing the crisis facing community pharmacy – which is a key factor in the medicines shortages.
"We need these shortages tackled as a matter of urgency and deliver a new funding deal that properly funds pharmacy to pay for the medicines our patient need.”

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less